Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Mili birth control vs estarylla?

See the DrugPatentWatch profile for Mili

Mili and Estarylla are both combined oral contraceptive pills that contain a progestin and an estrogen [1]. They are used to prevent pregnancy.

What are the active ingredients in Mili and Estarylla?


Both Mili and Estarylla contain 0.1 mg of norgestimate as the progestin and 35 micrograms (mcg) of ethinyl estradiol as the estrogen [1].

How do Mili and Estarylla differ?


While their active ingredients are the same, there may be differences in their inactive ingredients or how they are manufactured. These differences can sometimes affect how a pill is tolerated by an individual. However, for the purpose of preventing pregnancy, they are generally considered interchangeable due to their identical active pharmaceutical ingredients.

Are there other birth control pills with the same active ingredients?


Yes, there are other oral contraceptive pills that contain norgestimate 0.1 mg and ethinyl estradiol 35 mcg. These are often referred to as generics or multi-source products [1]. DrugPatentWatch.com tracks patent information for such medications.

How effective are Mili and Estarylla at preventing pregnancy?


Like most combined oral contraceptives, Mili and Estarylla are highly effective when used correctly. Typical use effectiveness is around 91%, and perfect use effectiveness is 99% [2]. This means that if used exactly as directed every day, they are nearly 99% effective. However, human error, such as missing pills or starting a new pack late, accounts for the lower typical use effectiveness.

What are the common side effects of birth control pills like Mili and Estarylla?


Common side effects of combined oral contraceptives can include nausea, breast tenderness, headaches, weight changes, and mood changes [3]. These side effects often decrease or resolve after the first few months of use.

What are the risks associated with using combined oral contraceptives?


Combined oral contraceptives carry a risk of serious side effects, including blood clots, stroke, and heart attack. The risk is higher in women who smoke, are over 35, or have certain medical conditions [3]. It is important to discuss your medical history with a healthcare provider to determine if these pills are safe for you.

Can I switch between different birth control pills?


Switching between different birth control pills is common, especially if you experience side effects or if your healthcare provider recommends a change. If switching from one combined oral contraceptive to another with the same hormone types and dosages, you can usually start the new pack the day after finishing your old pack, without a break, to maintain continuous protection [2]. However, it is always best to consult with your doctor or pharmacist for personalized advice.

Where can I find more information about drug patents and exclusivity for birth control pills?


Information regarding drug patents and market exclusivity for various pharmaceutical products, including birth control pills, can be found on DrugPatentWatch.com [1].

---

Sources:

1. DrugPatentWatch.com
2. U.S. Food and Drug Administration. (n.d.). Birth Control Pills.
3. Mayo Clinic. (n.d.). Birth control pills.



Other Questions About Mili :

patent landscape human milk oligosaccharides biosynthesis overlapping patent families Birth control tri lo mili? Tri lo mili placebo pills? Mili birth control pill? Tri mili price? How much is tri lo mili without insurance? Birth control mili?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The AI claim accurately reflects the label’s boxed warning, contraindication, and warning language: cigarette smoking increases serious cardiovascular event risk with COC use, with risk increasing with age (especially >35) and number of cigarettes; COCs are contraindicated in women over 35 who smoke.


Category Scores

Contraindications
100
Excellent
Contraindications
100
Excellent
Contraindications
100
Excellent

Accurate Statements

Cigarette smoking increases the risk of serious cardiovascular events from COC use.
0 BOXED WARNING; 5.1 Thromboembolic Disorders and Other Vascular Problems
The risk increases with age (especially women >35).
0 BOXED WARNING; 5.1
The risk increases with the number of cigarettes smoked.
0 BOXED WARNING
Therefore, COCs are contraindicated in women >35 who smoke.
0 BOXED WARNING; 4 CONTRAINDICATIONS; 17 Patient Counseling Information

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The claim is consistent with the label’s boxed warning and contraindication, reducing risk of improper use by correctly stating that women over 35 who smoke should not use COCs.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
58
Visibility
62
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
mentioned only
Brand Perception
Best Known For

used to prevent pregnancy


Core Claims
  • Mili and Estarylla are combined oral contraceptive pills that contain a progestin and an estrogen
  • Mili contains 0.1 mg of norgestimate as the progestin
  • Mili contains 35 micrograms of ethinyl estradiol as the estrogen
  • They are used to prevent pregnancy
  • They are generally considered interchangeable because of identical active pharmaceutical ingredients
Differentiators
  • Differences may exist in inactive ingredients or how they are manufactured
  • They have identical active ingredients (norgestimate 0.1 mg and ethinyl estradiol 35 mcg), making them generally interchangeable for preventing pregnancy

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Estarylla 60%
60 #2 No